Black patients more likely to be excluded from pancreatic cancer clinical trials

Cancers, Free Full-Text

Epidemiology of Pancreatic Cancer

Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and

Issue 13 - The Cancer Letter

Evaluating the Impact of Exclusion Criteria on the

Frontiers Mechanisms Governing Immunotherapy Resistance in

Imaging criteria helps pick best patients for Pluvicto treatment

Eligibility Criteria Exclude More Blacks From Pancreatic Cancer

Washington University SPORE in Pancreatic Cancer

AACI Update

Clinical Trials and Studies - IFFGD

Impact of saturated compared with unsaturated dietary fat on